Skip to main content
. 2020 Sep 27;25(19):4441. doi: 10.3390/molecules25194441

Table 4.

Peak areas of main absorbed constituents and their ratio between different administration groups (×106).

3,5-Dimethoxytoluene
(M60)
Safrole
(M64)
Methyleugenol
(M79)
2,3,5-Trimethoxytoluene
(M82)
3,4,5-Trimethoxytoluene
(M83)
Eugenol
(M93)
Kakuol
(M138)
P D Ratio P D Ratio P D Ratio P D Ratio P D Ratio P D Ratio P D Ratio
FE 7.19 n.d. / 3.25 0.0058 560.3 2.04 0.0052 392.3 3.45 0.005 690.0 4.07 0.01 407.0 0.10 0.02 5.4 1.36 0.70 1.9
UR 0.54 n.d. / 0.04 0.0038 10.5 0.12 0.0064 18.8 0.65 0.030 21.7 1.10 0.32 3.4 5.66 6.58 0.9 16.79 10.51 1.6
BL 2.68 n.d. / 2.54 n.d. / 0.5 n.d. / 1.91 0.032 59.7 2.11 0.31 6.8 n.d. n.d. / 0.10 0.02 6.4
BR 2.48 n.d. / 1.94 n.d. / 0.4 n.d. / 0.75 0.007 107.1 0.64 0.06 10.7 n.d. n.d. / 0.07 0.01 13.0
HE 1.45 n.d. / 0.98 n.d. / 0.26 n.d. / 0.54 0.007 77.1 0.46 0.05 9.2 n.d. 0.004 / 0.06 0.005 12.5
LU 1.27 n.d. / 0.98 n.d. / 0.24 n.d. / 0.39 0.008 48.8 0.33 0.05 6.6 0.05 0.01 5.2 0.09 0.01 10.9
SP 1.86 n.d. / 1.43 0.0004 3575.0 0.9 0.0016 562.5 0.97 0.009 107.8 0.59 0.06 9.8 0.02 0.01 3.0 0.16 0.01 21.7
LI 7.09 0.0017 4170.6 5.03 0.0012 4191.7 1.29 0.0032 403.1 2.26 0.031 72.9 1.89 0.24 7.9 0.05 0.02 2.6 0.05 0.04 1.2
KI 4.63 0.0019 2436.8 2.48 0.0018 1377.8 0.88 0.0051 172.5 2.58 0.056 46.1 2.78 0.56 5.0 0.22 0.23 0.9 1.13 0.31 3.6
ST 35.16 0.0025 14,064.0 46.54 n.d. / 34.99 0.0801 436.8 18.84 0.293 64.3 17.07 1.90 9.0 0.20 0.05 4.1 8.58 2.36 3.6
IN 13.06 0.0021 6219.0 16.02 0.0025 6408.0 12.38 0.0069 1794.2 6.56 0.026 252.3 5.83 0.13 44.8 0.06 0.12 0.5 2.01 0.22 9.2

P: powder-treated group; D: decoction-treated group; FE: feces; UR: urine; BL: blood; BR: brain; HE: heart; LU: lung; SP: spleen; LI: liver; KI: kidney; ST: stomach; IN: small intestine. Ratio: the ratio of peak areas between powder- and decoction-treated groups. n.d.: not detected. /: The ratio cannot be calculated because the constituents failed to be detected in the powder- or decoction-treated group.